阅读说明：本技术 辅助缓解焦虑和抑郁症状的含宝乐果粉的复合粉及其制备方法 (Compound powder containing Baoleguo powder for assisting in relieving anxiety and depression symptoms and preparation method thereof ) 是由 焦红 黄准 苏琳 王蕴 潘滔 胡烨敏 于 2021-10-22 设计创作，主要内容包括：本发明公开了辅助缓解焦虑和抑郁症状的含宝乐果粉的复合粉及其制备方法,配方包括：酸奶粉、宝乐果粉、维生素B6、叶酸、磷脂酰丝氨酸、低聚半乳糖、香芋粉、抗性糊精、瓜尔胶、二氧化硅、三氯蔗糖和乳酸菌,各组分的重量份数分别是：4999-5001份的酸奶粉、999-1001份的宝乐果粉、0.19-0.21份的维生素B6、0.04-0.06份的叶酸、199-201份的磷脂酰丝氨酸、999-1001份的低聚半乳糖、1499-1501份的香芋粉、612.74-612.76份的抗性糊精、399-401份的瓜尔胶、79-81份的二氧化硅、6.9-7.1份的三氯蔗糖和279-281份的乳酸菌,本发明为焦虑和抑郁类人群带来一种饮用食物,利用该配方制成的食物能改善患者单纯服抗抑郁药物带来的耐药副作用,减轻失眠和便秘症状及其产生的心理负担,在日常饮食中提高对抑郁症患者的缓解效率。(The invention discloses a composite powder containing Baoleguo powder for assisting in relieving anxiety and depression symptoms and a preparation method thereof, wherein the formula comprises the following components: the formula comprises the following components in parts by weight: 4999A medicine for treating depression and insomnia is prepared from 5001 parts of yoghurt powder, 1001 parts of Baoleguo powder, 0.19-0.21 part of vitamin B6, 0.04-0.06 part of folic acid, 201 parts of phosphatidylserine, 1001 parts of 999-1001 parts of galactooligosaccharide, 1499A 1501 parts of henry steudnera tuber powder, 612.74-612.76 parts of resistant dextrin, 399A 401 parts of guar gum, 79-81 parts of silicon dioxide, 6.9-7.1 parts of sucralose and 279A 281 parts of lactic acid bacteria.)

1. The compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following components in percentage by weight: the fermented milk powder is characterized by comprising the following components in parts by weight: the weight parts of the components are respectively as follows: 4999-5001 parts of yoghurt powder, 999-1001 parts of Baoleguo powder, 0.19-0.21 part of vitamin B6, 0.04-0.06 part of folic acid, 199-201 parts of phosphatidylserine, 999-1001 parts of galacto-oligosaccharide, 1499-1501 parts of henry steudnera tuber powder, 612.74-612.76 parts of resistant dextrin, 399-401 parts of guar gum, 79-81 parts of silicon dioxide, 6.9-7.1 parts of sucralose and 279-281 parts of lactic acid bacteria.

2. The preparation method of the compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following steps of firstly, selecting materials; step two, sieving; weighing the materials; step four, total mixing; step five, subpackaging; step six, outer packing; step seven, checking; step eight, warehousing; the method is characterized in that:

in the first step, selecting yoghurt powder, Baoleguo powder, vitamin B6, folic acid, phosphatidylserine, galacto-oligosaccharide, taro powder, resistant dextrin, guar gum, silicon dioxide, sucralose, lactic acid bacteria and packaging materials which meet the standard requirements for inspection to prepare for later use;

in the second step, the raw materials selected in the first step are sequentially screened through a screen for later use;

wherein in the third step, the sour milk powder of 4999-5001 parts, the Bordetella powder of 999-1001 parts, the vitamin B6 of 0.19-0.21 part, the folic acid of 0.04-0.06 part, the phosphatidylserine of 199-201 parts, the galacto-oligosaccharide of 999-1001 parts, the henry steudnera powder of 1499-1501 parts, the resistant dextrin of 612.74-612.76 parts, the guar gum of 399-401 parts, the silicon dioxide of 79-81 parts, the trichlorosucrose of 6.9-7.1 parts and the trichlorosucrose of 27 parts are respectively weighed according to the parts by weight of the components9-281 parts of lactobacillus for standby, and the content of viable bacteria in the lactobacillus is 2.0 multiplied by 10¹²CFU/g；

In the fourth step, the raw materials weighed in the third step are sequentially put into a mixer to be uniformly mixed to obtain mixed powder;

in the fifth step, the mixed powder obtained in the fourth step is packaged in bags by a particle packaging machine, and the filling quantity difference, the sealing condition, the appearance and the like are checked in time;

in the sixth step, each bag of the objects subpackaged in the fifth step is subjected to product external packaging according to the packaging requirements, and packaging quality inspection is carried out to obtain a semi-finished product;

in the seventh step, the semi-finished product obtained in the sixth step is inspected according to the product quality requirement;

and step eight, sampling and inspecting the to-be-inspected product to obtain a qualified product, and warehousing the qualified product to obtain a finished product.

3. The method for preparing the composite powder containing the boletus fruit powder for assisting in relieving the symptoms of anxiety and depression according to claim 2, wherein the method comprises the following steps: in the second step, the mesh number of the screen is 60 meshes.

4. The method for preparing the composite powder containing the boletus fruit powder for assisting in relieving the symptoms of anxiety and depression according to claim 2, wherein the method comprises the following steps: in the fourth step, the mixing time is 30-35min, and meanwhile, the water content of the mixture is ensured to be 3-6%.

5. The method for preparing the composite powder containing the boletus fruit powder for assisting in relieving the symptoms of anxiety and depression according to claim 2, wherein the method comprises the following steps: and in the fifth step, packaging the bags according to the standard of 10.0g per bag.

6. The method for preparing the composite powder containing the boletus fruit powder for assisting in relieving the symptoms of anxiety and depression according to claim 2, wherein the method comprises the following steps: in the fifth step, the relative humidity of the environment packaged in bags is 45-65%.

7. The method for preparing the composite powder containing the boletus fruit powder for assisting in relieving the symptoms of anxiety and depression according to claim 2, wherein the method comprises the following steps: in the fifth step, the sampling inspection is carried out once every 30min, so that the filling amount difference of each bag is +/-3% of the weight of each bag.

Technical Field

The invention relates to the technical field of food production, in particular to composite powder containing Baoleguo powder for assisting in relieving anxiety and depression symptoms and a preparation method thereof.

Background

Anxiety and depression symptoms are remarkable and persistent mood depression, thought retardation, cognitive function impairment, mental hypoactivity and clinical symptoms such as insomnia, constipation, anxiety and the like which are generally accompanied by serious, the life quality of patients is reduced, the patients feel hopeless in the future and even want suicide or autonomy, and in recent decades, with the rapid development and the accelerated life rhythm of modern society, particularly young people between 20 and 40 years old, the stress bearing capacity is high, the depression incidence is rapidly increased, and the symptoms become the second cause of death and disability all over the world in 2020. Depression is a disease symptom with complex etiology, can only be treated by medicaments at present, but the tolerance is poor and the remission rate is low after long-term administration, meanwhile, intestinal flora imbalance, constipation and insomnia are mostly accompanied by depression patients, the symptoms aggravate the pain of the depression patients, the composite powder containing the Baoleguo powder for assisting in relieving the anxiety and the depression symptoms and the preparation method thereof are designed, a drinking food is brought to the anxiety and depression groups, the food can improve the drug resistance side effect brought by the patients who simply take the antidepressant medicaments, relieve the insomnia and the constipation symptoms and the psychological burden generated by the insomnia and the constipation symptoms, and improve the relief efficiency of the depression patients in daily diet.

Disclosure of Invention

The invention aims to provide composite powder containing Baoleguo powder for assisting in relieving anxiety and depression symptoms and a preparation method thereof, so as to solve the problems in the background technology.

In order to solve the technical problems, the invention provides the following technical scheme: the compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following components in percentage by weight: the formula comprises the following components in parts by weight: 4999-5001 parts of yoghurt powder, 999-1001 parts of Baoleguo powder, 0.19-0.21 part of vitamin B6, 0.04-0.06 part of folic acid, 199-201 parts of phosphatidylserine, 999-1001 parts of galacto-oligosaccharide, 1499-1501 parts of henry steudnera tuber powder, 612.74-612.76 parts of resistant dextrin, 399-401 parts of guar gum, 79-81 parts of silicon dioxide, 6.9-7.1 parts of sucralose and 279-281 parts of lactic acid bacteria.

The preparation method of the compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following steps of firstly, selecting materials; step two, sieving; weighing the materials; step four, total mixing; step five, subpackaging; step six, outer packing; step seven, checking; step eight, warehousing;

in the first step, selecting yoghurt powder, Baoleguo powder, vitamin B6, folic acid, phosphatidylserine, galacto-oligosaccharide, taro powder, resistant dextrin, guar gum, silicon dioxide, sucralose, lactic acid bacteria and packaging materials which meet the standard requirements for inspection to prepare for later use;

in the second step, the raw materials selected in the first step are sequentially screened through a screen for later use;

wherein in the third step, 5001 parts of yoghurt powder, 1001 parts of Baoleguo powder, 0.19-0.21 parts of vitamin B6, 0.04-0.06 parts of folic acid, 201 parts of phosphatidyl serine and 1001 parts of low-content vitamin B are respectively weighed according to the parts by weight of the componentsPolygalactose, 1499-1501 parts of taro powder, 612.74-612.76 parts of resistant dextrin, 399-401 parts of guar gum, 79-81 parts of silicon dioxide, 6.9-7.1 parts of sucralose and 279-281 parts of lactic acid bacteria for later use, wherein the content of viable bacteria in the lactic acid bacteria is 2.0 multiplied by 10¹²CFU/g；

In the fourth step, the raw materials weighed in the third step are sequentially put into a mixer to be uniformly mixed to obtain mixed powder;

in the fifth step, the mixed powder obtained in the fourth step is packaged in bags by a particle packaging machine, and the filling quantity difference, the sealing condition, the appearance and the like are checked in time;

in the sixth step, each bag of the objects subpackaged in the fifth step is subjected to product external packaging according to the packaging requirements, and packaging quality inspection is carried out to obtain a semi-finished product;

in the seventh step, the semi-finished product obtained in the sixth step is inspected according to the product quality requirement;

and step eight, sampling and inspecting the to-be-inspected product to obtain a qualified product, and warehousing the qualified product to obtain a finished product.

According to the technical scheme, in the second step, the mesh number of the screen is 60 meshes.

According to the technical scheme, in the fourth step, the mixing time is 30-35min, and meanwhile, the water content of the mixture is ensured to be 3-6%.

According to the technical scheme, in the fifth step, the bags are packaged according to the standard of 10.0g per bag.

According to the technical scheme, in the fifth step, the relative humidity of the environment packaged in the bags is 45-65%.

According to the technical scheme, in the fifth step, the sampling inspection is carried out once every 30min, so that the difference of the filling amount of each bag is +/-3% of the weight of each bag.

Compared with the prior art, the invention has the following beneficial effects: according to the invention, antioxidant substances such as polyphenol, total flavone, monoterpene active substances, polyterpene, organic acid and crude polysaccharide contained in the Bordeaux powder are utilized to directly stimulate enteric wall nerves, accelerate intestinal peristalsis, and simultaneously reduce the pH value of an intestinal tract to inhibit the growth of pathogenic bacteria, so that the intestinal microenvironment is improved, the colonization and proliferation of probiotics are promoted, non-probiotics and the effects of the non-probiotics are reduced, the intestinal flora microenvironment of a depression patient is further changed, the cell metabolism is promoted, a large amount of short chain fatty acids are generated, the constipation or stool dilution symptom is relieved, the psychological burden of the patient is reduced, and the depression symptom is relieved; meanwhile, high-content tryptophan in the yoghurt powder is utilized to convert and secrete monoamine transmitters such as 5-HT, norepinephrine and dopamine in intestinal tracts to enter blood, and the abnormality of a nervous system caused by the reduction of the monoamine transmitters among synapses is repaired through a brain-intestinal axis, so that the symptoms of depression and indigestion are relieved; meanwhile, the gamma-aminobutyric acid naturally contained in the Borojo powder and the gamma-aminobutyric acid secreted by probiotics planted and grown in intestinal tracts act together with neurotrophic repair components such as vitamin B6, folic acid, phosphatidylserine and the like in the formula, and the neurotransmitter is indirectly influenced to participate in the physiological process of the brain, so that the insomnia caused by vexation and anxiety is changed, and the anxiety symptoms are relieved; the taro powder, the guar gum and the sucralose in the formula improve the drinking taste of the composite powder, avoid the psychological resistance of the composite powder caused by long-time drinking, and further improve the relieving efficiency of the composite powder to depression patients.

Drawings

The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the principles of the invention and not to limit the invention.

In the drawings:

FIG. 1 is a flow chart of the method of the present invention.

Detailed Description

The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.

Referring to fig. 1, the present invention provides a technical solution:

example 1:

the compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following components in percentage by weight: the formula comprises the following components in parts by weight: 4999-5001 parts of yoghurt powder, 999-1001 parts of Baoleguo powder, 0.19-0.21 part of vitamin B6, 0.04-0.06 part of folic acid, 199-201 parts of phosphatidylserine, 999-1001 parts of galacto-oligosaccharide, 1499-1501 parts of henry steudnera tuber powder, 612.74-612.76 parts of resistant dextrin, 399-401 parts of guar gum, 79-81 parts of silicon dioxide, 6.9-7.1 parts of sucralose and 279-281 parts of lactic acid bacteria.

The preparation method of the compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following steps of firstly, selecting materials; step two, sieving; weighing the materials; step four, total mixing; step five, subpackaging; step six, outer packing; step seven, checking; step eight, warehousing;

in the first step, selecting yoghurt powder, Baoleguo powder, vitamin B6, folic acid, phosphatidylserine, galacto-oligosaccharide, taro powder, resistant dextrin, guar gum, silicon dioxide, sucralose, lactic acid bacteria and packaging materials which meet the standard requirements for inspection to prepare for later use;

in the second step, the raw materials selected in the first step are sequentially screened by a screen mesh for later use, and the mesh number of the screen mesh is 60 meshes;

in the third step, 4999 parts of yoghurt powder, 999 parts of Borojo powder, 0.19 part of vitamin B6, 0.04 part of folic acid, 199 parts of phosphatidylserine, 999 parts of galacto-oligosaccharide, 1499 parts of henry steudnera tuber powder, 612.74 parts of resistant dextrin, 399 parts of guar gum, 79 parts of silicon dioxide, 6.9 parts of sucralose and 279 parts of lactic acid bacteria are respectively weighed according to the parts by weight of the components, and the content of viable bacteria in the lactic acid bacteria is 2.0 multiplied by 10¹²CFU/g；

In the fourth step, the raw materials weighed in the third step are sequentially put into a mixer to be uniformly mixed to obtain mixed powder, the mixing time is 30-35min, and meanwhile, the water content of the mixture is ensured to be 3-6%;

in the fifth step, the mixed powder obtained in the fourth step is packaged in bags by a particle packaging machine, and the bags are packaged in bags according to the standard of 10.0g per bag, meanwhile, the relative humidity of the environment of the bags is 45-65%, the humidity is used for checking the filling quantity difference, the sealing condition, the appearance and the like in time, and meanwhile, the sampling inspection is carried out once every 30min, so that the filling quantity difference of each bag is +/-3% of the weight of each bag;

in the sixth step, each bag of the objects subpackaged in the fifth step is subjected to product external packaging according to the packaging requirements, and packaging quality inspection is carried out to obtain a semi-finished product;

in the seventh step, the semi-finished product obtained in the sixth step is inspected according to the product quality requirement;

and step eight, sampling and inspecting the to-be-inspected product to obtain a qualified product, and warehousing the qualified product to obtain a finished product.

Example 2:

the compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following components in percentage by weight: the formula comprises the following components in parts by weight: 4999-5001 parts of yoghurt powder, 999-1001 parts of Baoleguo powder, 0.19-0.21 part of vitamin B6, 0.04-0.06 part of folic acid, 199-201 parts of phosphatidylserine, 999-1001 parts of galacto-oligosaccharide, 1499-1501 parts of henry steudnera tuber powder, 612.74-612.76 parts of resistant dextrin, 399-401 parts of guar gum, 79-81 parts of silicon dioxide, 6.9-7.1 parts of sucralose and 279-281 parts of lactic acid bacteria.

The preparation method of the compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following steps of firstly, selecting materials; step two, sieving; weighing the materials; step four, total mixing; step five, subpackaging; step six, outer packing; step seven, checking; step eight, warehousing;

in the first step, selecting yoghurt powder, Baoleguo powder, vitamin B6, folic acid, phosphatidylserine, galacto-oligosaccharide, taro powder, resistant dextrin, guar gum, silicon dioxide, sucralose, lactic acid bacteria and packaging materials which meet the standard requirements for inspection to prepare for later use;

in the second step, the raw materials selected in the first step are sequentially screened by a screen mesh for later use, and the mesh number of the screen mesh is 60 meshes;

in the third step, 5001 parts of yoghurt powder, 1001 parts of Bordeaux fruit powder, 0.21 parts of vitamin B6, 0.06 parts of folic acid, 201 parts of phosphatidylserine, 1001 parts of galacto-oligosaccharide, 1501 parts of henry steudnera tuber powder, 612.76 parts of resistant dextrin, 401 parts of guar gum, 81 parts of silicon dioxide, 7.1 parts of sucralose and 281 parts of lactic acid bacteria screened in the second step are respectively weighed according to the parts by weight of the components for later use, and the content of viable bacteria in the lactic acid bacteria is 2.0 multiplied by 10¹²CFU/g；

In the fourth step, the raw materials weighed in the third step are sequentially put into a mixer to be uniformly mixed to obtain mixed powder, the mixing time is 30-35min, and meanwhile, the water content of the mixture is ensured to be 3-6%;

in the fifth step, the mixed powder obtained in the fourth step is packaged in bags by a particle packaging machine, and the bags are packaged in bags according to the standard of 10.0g per bag, meanwhile, the relative humidity of the environment of the bags is 45-65%, the humidity is used for checking the filling quantity difference, the sealing condition, the appearance and the like in time, and meanwhile, the sampling inspection is carried out once every 30min, so that the filling quantity difference of each bag is +/-3% of the weight of each bag;

in the sixth step, each bag of the objects subpackaged in the fifth step is subjected to product external packaging according to the packaging requirements, and packaging quality inspection is carried out to obtain a semi-finished product;

in the seventh step, the semi-finished product obtained in the sixth step is inspected according to the product quality requirement;

and step eight, sampling and inspecting the to-be-inspected product to obtain a qualified product, and warehousing the qualified product to obtain a finished product.

Example 3:

the compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following components in percentage by weight: the formula comprises the following components in parts by weight: 4999-5001 parts of yoghurt powder, 999-1001 parts of Baoleguo powder, 0.19-0.21 part of vitamin B6, 0.04-0.06 part of folic acid, 199-201 parts of phosphatidylserine, 999-1001 parts of galacto-oligosaccharide, 1499-1501 parts of henry steudnera tuber powder, 612.74-612.76 parts of resistant dextrin, 399-401 parts of guar gum, 79-81 parts of silicon dioxide, 6.9-7.1 parts of sucralose and 279-281 parts of lactic acid bacteria.

The preparation method of the compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following steps of firstly, selecting materials; step two, sieving; weighing the materials; step four, total mixing; step five, subpackaging; step six, outer packing; step seven, checking; step eight, warehousing;

in the first step, selecting yoghurt powder, Baoleguo powder, vitamin B6, folic acid, phosphatidylserine, galacto-oligosaccharide, taro powder, resistant dextrin, guar gum, silicon dioxide, sucralose, lactic acid bacteria and packaging materials which meet the standard requirements for inspection to prepare for later use;

in the second step, the raw materials selected in the first step are sequentially screened by a screen mesh for later use, and the mesh number of the screen mesh is 60 meshes;

in the third step, 5000 parts of yoghurt powder, 1000 parts of Borojo powder, 0.2 part of vitamin B6, 0.05 part of folic acid, 200 parts of phosphatidylserine, 1000 parts of galacto-oligosaccharide, 1500 parts of taro powder, 612.75 parts of resistant dextrin, 400 parts of guar gum, 80 parts of silicon dioxide, 7 parts of sucralose and 280 parts of lactic acid bacteria are respectively weighed according to the parts by weight of the components, and the content of viable bacteria in the lactic acid bacteria is 2.0 multiplied by 10¹²CFU/g；

In the fourth step, the raw materials weighed in the third step are sequentially put into a mixer to be uniformly mixed to obtain mixed powder, the mixing time is 30-35min, and meanwhile, the water content of the mixture is ensured to be 3-6%;

in the fifth step, the mixed powder obtained in the fourth step is packaged in bags by a particle packaging machine, and the bags are packaged in bags according to the standard of 10.0g per bag, meanwhile, the relative humidity of the environment of the bags is 45-65%, the humidity is used for checking the filling quantity difference, the sealing condition, the appearance and the like in time, and meanwhile, the sampling inspection is carried out once every 30min, so that the filling quantity difference of each bag is +/-3% of the weight of each bag;

in the sixth step, each bag of the objects subpackaged in the fifth step is subjected to product external packaging according to the packaging requirements, and packaging quality inspection is carried out to obtain a semi-finished product;

in the seventh step, the semi-finished product obtained in the sixth step is inspected according to the product quality requirement;

and step eight, sampling and inspecting the to-be-inspected product to obtain a qualified product, and warehousing the qualified product to obtain a finished product.

Example 4:

the compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following components in percentage by weight: the formula comprises the following components in parts by weight: 4999-5001 parts of yoghurt powder, 999-1001 parts of Baoleguo powder, 0.19-0.21 part of vitamin B6, 0.04-0.06 part of folic acid, 199-201 parts of phosphatidylserine, 999-1001 parts of galacto-oligosaccharide, 1499-1501 parts of henry steudnera tuber powder, 612.74-612.76 parts of resistant dextrin, 399-401 parts of guar gum, 79-81 parts of silicon dioxide, 6.9-7.1 parts of sucralose and 279-281 parts of lactic acid bacteria.

The preparation method of the compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following steps of firstly, selecting materials; step two, sieving; weighing the materials; step four, total mixing; step five, subpackaging; step six, outer packing; step seven, checking; step eight, warehousing;

in the first step, selecting yoghurt powder, Baoleguo powder, vitamin B6, folic acid, phosphatidylserine, galacto-oligosaccharide, taro powder, resistant dextrin, guar gum, silicon dioxide, sucralose, lactic acid bacteria and packaging materials which meet the standard requirements for inspection to prepare for later use;

in the second step, the raw materials selected in the first step are sequentially screened by a screen mesh for later use, and the mesh number of the screen mesh is 60 meshes;

in the third step, 5001 parts of yoghurt powder, 999 parts of Borojo powder, 0.19 part of vitamin B6, 0.04 part of folic acid, 199 parts of phosphatidylserine, 999 parts of galacto-oligosaccharide, 1501 parts of henry steudnera tuber powder, 612.76 parts of resistant dextrin, 399 parts of guar gum, 79 parts of silicon dioxide, 6.9 parts of sucralose and 279 parts of lactic acid bacteria screened in the second step are respectively weighed according to the parts by weight of the components for later use, and the content of viable bacteria in the lactic acid bacteria is 2.0 multiplied by 10¹²CFU/g；

In the fourth step, the raw materials weighed in the third step are sequentially put into a mixer to be uniformly mixed to obtain mixed powder, the mixing time is 30-35min, and meanwhile, the water content of the mixture is ensured to be 3-6%;

in the fifth step, the mixed powder obtained in the fourth step is packaged in bags by a particle packaging machine, and the bags are packaged in bags according to the standard of 10.0g per bag, meanwhile, the relative humidity of the environment of the bags is 45-65%, the humidity is used for checking the filling quantity difference, the sealing condition, the appearance and the like in time, and meanwhile, the sampling inspection is carried out once every 30min, so that the filling quantity difference of each bag is +/-3% of the weight of each bag;

in the sixth step, each bag of the objects subpackaged in the fifth step is subjected to product external packaging according to the packaging requirements, and packaging quality inspection is carried out to obtain a semi-finished product;

in the seventh step, the semi-finished product obtained in the sixth step is inspected according to the product quality requirement;

and step eight, sampling and inspecting the to-be-inspected product to obtain a qualified product, and warehousing the qualified product to obtain a finished product.

Example 5:

the compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following components in percentage by weight: the formula comprises the following components in parts by weight: 4999-5001 parts of yoghurt powder, 999-1001 parts of Baoleguo powder, 0.19-0.21 part of vitamin B6, 0.04-0.06 part of folic acid, 199-201 parts of phosphatidylserine, 999-1001 parts of galacto-oligosaccharide, 1499-1501 parts of henry steudnera tuber powder, 612.74-612.76 parts of resistant dextrin, 399-401 parts of guar gum, 79-81 parts of silicon dioxide, 6.9-7.1 parts of sucralose and 279-281 parts of lactic acid bacteria.

The preparation method of the compound powder containing the Baoleguo powder for assisting in relieving the symptoms of anxiety and depression comprises the following steps of firstly, selecting materials; step two, sieving; weighing the materials; step four, total mixing; step five, subpackaging; step six, outer packing; step seven, checking; step eight, warehousing;

in the first step, selecting yoghurt powder, Baoleguo powder, vitamin B6, folic acid, phosphatidylserine, galacto-oligosaccharide, taro powder, resistant dextrin, guar gum, silicon dioxide, sucralose, lactic acid bacteria and packaging materials which meet the standard requirements for inspection to prepare for later use;

in the second step, the raw materials selected in the first step are sequentially screened by a screen mesh for later use, and the mesh number of the screen mesh is 60 meshes;

in the third step, 5001 parts of yoghurt powder, 1001 parts of Bordeaux fruit powder, 0.21 part of vitamin B6, 0.06 part of folic acid, 199 parts of phosphatidylserine, 999 parts of galacto-oligosaccharide, 1499 parts of henry steudnera tuber powder, 612.76 parts of resistant dextrin, 399 parts of guar gum, 79 parts of silicon dioxide, 7.1 parts of sucralose and 279 parts of lactic acid bacteria screened in the second step are respectively weighed according to the parts by weight of the components for later use, and the viable bacteria content in the lactic acid bacteria is 2.0 multiplied by 10¹²CFU/g；

In the fourth step, the raw materials weighed in the third step are sequentially put into a mixer to be uniformly mixed to obtain mixed powder, the mixing time is 30-35min, and meanwhile, the water content of the mixture is ensured to be 3-6%;

in the fifth step, the mixed powder obtained in the fourth step is packaged in bags by a particle packaging machine, and the bags are packaged in bags according to the standard of 10.0g per bag, meanwhile, the relative humidity of the environment of the bags is 45-65%, the humidity is used for checking the filling quantity difference, the sealing condition, the appearance and the like in time, and meanwhile, the sampling inspection is carried out once every 30min, so that the filling quantity difference of each bag is +/-3% of the weight of each bag;

in the sixth step, each bag of the objects subpackaged in the fifth step is subjected to product external packaging according to the packaging requirements, and packaging quality inspection is carried out to obtain a semi-finished product;

in the seventh step, the semi-finished product obtained in the sixth step is inspected according to the product quality requirement;

and step eight, sampling and inspecting the to-be-inspected product to obtain a qualified product, and warehousing the qualified product to obtain a finished product.

The finished products obtained in the above examples were tested separately, and the results are shown in the following table:

the product obtained in example 1 is administered to 5 volunteers who are not suffering from severe physical diseases, brain organic diseases, pregnancy or lactation, are not drug abusers and have no antibiotics in the last month and are aged 22-60 years, 5 volunteers are self-tested according to the SDS and SAS scales and have scores of about 50-60, are diagnosed by a physician and have mild-moderate depression or anxiety symptom manifestations, and then are subjected to test feeding, questionnaires are matched before and after the end of the test feeding activity to provide whole plasma and fresh stool samples, and the test comparison of the monoamine nervous substances, short-chain fatty acids and 9 enteric bacteria levels in the whole plasma and the stool is performed, and the following results are obtained:

wherein the following table is a record of changes in perception of symptoms of SAS and SDS after one month of product feeding, and n is 5, as follows:

the following table shows short chain fatty acid change (scFA) g/100g, mean analysis results before and after product feeding, where wet stool n is 5, as follows:

the following table is a table of changes in 3 neuromediators before and after a product test, wherein n-5 is in human whole plasma, and the table is as follows:

the following table shows the change table of intestinal flora of 9 items before and after the product is eaten, wherein n-5 is given in human wet stool, and the table is as follows:

the following table is a B/E table of bifidobacteria and enterobacteria before and after the product is fed on trial, and the table is as follows:

the invention has the advantages that the Bordeaux powder is added in the formula, plant nutrients such as high-content antioxidant substances, namely polyphenol, total flavone, monoterpene active substances, polyterpene and sterols thereof, various organic acids, crude polysaccharide and the like, which are naturally contained in the Bordeaux powder are utilized to directly stimulate enteric wall nerves, accelerate intestinal peristalsis, reduce the pH value of an intestinal tract to inhibit the growth of pathogenic bacteria, improve the microenvironment of the intestinal tract, promote the colonization and proliferation of the probiotic bacteria, reduce non-probiotic bacteria and the action thereof, further change the intestinal tract flora of a depression patient and relieve the constipation symptom of the depression patient, meanwhile, the non-probiotic advantages of the intestinal tract flora of the depression patient are changed by utilizing the galactooligosaccharide and the lactic acid bacteria in the formula to serve as the prebiotics and the probiotics, so that the probiotics are changed into dominant bacteria, the functions of the intestinal tract flora are adjusted, and the dietary absorption and metabolism of the patient are improved after the intestinal tract metabolic system is optimized, creates a good intestinal microenvironment, thereby utilizing the brain intestinal axis effect to stimulate the central nervous system, reducing the psychological burden of patients and relieving depression symptoms; the formula contains high-content tryptophan which is converted into 5-HT in an intestinal system, the content of other monoamines such as norepinephrine, dopamine and the like is adjusted and increased through a monoamine metabolic system, the damage of a nervous system is repaired through a brain-intestinal axis, and the displeasure of depression caused by 5-hydroxytryptamine deficiency and the negative depression symptom caused by the deficiency of norepinephrine and dopamine of a patient are improved; meanwhile, the natural gamma-aminobutyric acid in the Borojo powder and the neurotrophic components such as formula vitamin B6, folic acid, phosphatidylserine and the like are utilized to change insomnia caused by vexation and anxiety and relieve anxiety symptoms; the taro powder, the guar gum and the sucralose in the formula improve the drinking taste of the composite powder, avoid the psychological resistance of the composite powder caused by long-time drinking, the composite powder brings a drinking food for anxiety and depression people, the food can improve the drug resistance side effect of patients who simply take antidepressant drugs, reduce the insomnia and constipation symptoms and the psychological burden generated by the insomnia and constipation symptoms, the relieving efficiency of the depression patients is improved in daily diet, meanwhile, according to the experimental results, the galactooligosaccharide and the lactic acid bacteria in the formula are used as the prebiotics and the probiotics, the non-probiotic dominant bacteria of the intestinal flora of the depression patients are changed into the probiotic dominant bacteria, a good intestinal environment is created, the constipation symptom is relieved, thereby stimulating the central nervous system through the brain-intestine axis effect, reducing the psychological burden of patients, relieving depression symptoms, and having obvious difference of the log-value ratio B/E of bifidobacteria and enterobacteria before and after the product is eaten; according to the invention, by regulating the function of intestinal flora, the intestinal flora microenvironment is optimized, the intestinal bacterial metabolism is promoted, the dietary absorption and metabolism of patients are improved, a large amount of short-chain fatty acids are generated, the short-chain fatty acids are increased before and after the product is used, and the constipation symptom of the patients is improved to ensure normal defecation; the high-content tryptophan is converted into 5-HT in an intestinal system, monoamine substances such as noradrenaline and dopamine are regulated and increased to enter blood through a monoamine metabolic system, the damage of a nervous system is repaired through a brain-intestinal axis, and depression symptoms such as depression and negative depression caused by the deficiency of 5-hydroxytryptamine, noradrenaline and dopamine are improved; meanwhile, the natural gamma-aminobutyric acid in the boletus fruit powder and the auxiliary materials of vitamin B6, folic acid, phosphatidylserine and other neurotrophic components are utilized to change insomnia caused by vexation and anxiety and relieve anxiety symptoms, wherein the nightmare symptoms which are poor in sleep quality and frequently caused by nightmare symptoms are obviously relieved 1 person a week after the trial feeding and are obviously relieved 5 persons after 4 weeks; the constipation symptom is not obviously changed in 5 people in the first week, and is obviously relieved in 5 people in the fourth week; fatigue is felt without reason, fear and tension are easier than usual, and the symptoms cannot be calmed, 1 person is relieved in the first week, 4 persons are not obviously changed, and 4 persons are relieved without obvious change to 1 person in the fourth week; the taro powder, the guar gum and the sucralose in the formula improve the drinking taste of the composite powder, and avoid the resistance psychology to the composite powder caused by long-time drinking.

In conclusion, the composite powder containing the tylophora floribunda powder for assisting in relieving anxiety and depression symptoms acts on the microecological balance of an intestinal tract system, assists in the intestinal colonization of probiotics, and serves as a daily drinking food supplement to replace an antidepressant anxiety drug; tryptophan in the compound powder containing the Borax powder for assisting in relieving anxiety and depression symptoms has the functions of directly participating in metabolism of monoamine transmitter 5-hydroxytryptamine between nerve synapses of intestinal tracts and influencing the central nervous system to improve depression symptoms.

It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.

Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that changes may be made in the embodiments and/or equivalents thereof without departing from the spirit and scope of the invention. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.